Hydantoine derivatives as CD38 inhibitors

The present invention relates to compounds of formula I which have CD38 inhibitory activity and are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of inflammatory diseases.

Saved in:
Bibliographic Details
Main Authors BALOGH, MÁRIA, BUZDER-LANTOS, PÉTER, VASAS, ATTILA, BÁTORI, SÁNDOR, KAPUI, ZOLTÁN, FERENCZY, GYÖRGY, SZABÓ, TIBOR, URBÁN-SZABÓ, KATALIN
Format Patent
LanguageEnglish
French
German
Published 12.11.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula I which have CD38 inhibitory activity and are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of inflammatory diseases.
Bibliography:Application Number: EP20130462001